SHH and Stroke: Because aging is the most important risk factor for stroke, and aged patients and animals exhibit impaired stroke recovery [37, 38] to best mimic a clinically relevant scenario, we utilized aged mice [39, 40] (20–22 months) in which TAM administration enabled us to delete shh gene in nestin-expressing cells when TAM is present in vivo.